Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Oramed Pharmaceuticals (ORMP) Debt Ratio (2016 - 2024)

Oramed Pharmaceuticals filings provide 11 years of Debt Ratio readings, the most recent being 0.16 for Q1 2024.

  • Quarterly Debt Ratio changed N/A to 0.16 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 0.16 through Mar 2024, changed N/A year-over-year, with the annual reading at 0.23 for FY2023, N/A changed from the prior year.
  • Debt Ratio hit 0.16 in Q1 2024 for Oramed Pharmaceuticals, down from 0.23 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.33 in Q3 2023 and bottomed at 0.0 in Q2 2021.
  • Average Debt Ratio over 4 years is 0.08, with a median of 0.0 recorded in 2020.
  • The largest annual shift saw Debt Ratio increased 9.39% in 2020 before it plummeted 33.48% in 2021.
  • Oramed Pharmaceuticals' Debt Ratio stood at 0.0 in 2020, then plummeted by 68.26% to 0.0 in 2021, then skyrocketed by 31999.37% to 0.23 in 2023, then tumbled by 31.99% to 0.16 in 2024.
  • Per Business Quant, the three most recent readings for ORMP's Debt Ratio are 0.16 (Q1 2024), 0.23 (Q4 2023), and 0.33 (Q3 2023).